Evidence map›Paper›PMID 34439796›Full record

ReviewBiomolecules2021

Understanding the Therapeutic Potential of Ascorbic Acid in the Battle to Overcome Cancer.

Jurnal Reang, Prabodh Chander Sharma, Vijay Kumar Thakur, Jaseela Majeed

Open access · goldAbstract readReview
In one paragraph

Review in Biomolecules, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Sequential Supercritical COPlants (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Green Tea: Current Knowledge and Issues.Foods (Basel, Switzerland) · 2025
    Review
  10. Review
  11. Article
  12. Leaf extract ofFrontiers in pharmacology · 2024
    Article
  13. Article
  14. Article
  15. Plants (Basel, Switzerland) · 2023
    Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Jurnal ReangDepartment of Pharmaceutical Chemistry, School of Pharmaceutical Sciences, Delhi Pharmaceutical Sciences and Research University (DPSRU), New Delhi 110017, India.
Prabodh Chander SharmaDepartment of Pharmaceutical Chemistry, School of Pharmaceutical Sciences, Delhi Pharmaceutical Sciences and Research University (DPSRU), New Delhi 110017, India.ORCID 0000-0003-1920-3855
Vijay Kumar ThakurBiorefining and Advanced Materials Research Centre, Scotland's Rural College (SRUC), Kings Buildings, Edinburgh EH9 3JG, UK.ORCID 0000-0002-0790-2264
Jaseela MajeedSchool of Allied Health Sciences, Delhi Pharmaceutical Sciences and Research University (DPSRU), New Delhi 110017, India.
Delhi Pharmaceutical Science and Research University · INScotland's Rural College · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer, a fatal disease, is also one of the main causes of death worldwide. Despite various developments to prevent and treat cancer, the side effects of anticancer drugs remain a major concern. Ascorbic acid is an essential vitamin required by our bodies for normal physiological function and also has antioxidant and anticancer activity. Although the body cannot synthesize ascorbic acid, it is abundant in nature through foods and other natural sources and also exists as a nutritional food supplement. In anticancer drug development, ascorbic acid has played an important role by inhibiting the development of cancer through various mechanisms, including scavenging reactive oxygen species (ROS), selectively producing ROS and encouraging their cytotoxicity against tumour cells, preventing glucose metabolism, serving as an epigenetic regulator, and regulating the expression of HIF in tumour cells. Several ascorbic acid analogues have been produced to date for their anticancer and antioxidant activity. The current review summarizes the mechanisms behind ascorbic acid's antitumor activity, presents a compilation of its derivatives and their biological activity as anticancer agents, and discusses delivery systems such as liposomes, nanoparticles against cancer, and patents on ascorbic acid as anticancer agents.

Indexed as

Dietary SupplementsGene Expression Regulation, NeoplasticAntineoplastic AgentsAntioxidantsAscorbic AcidBiotransformationDrug CarriersEpigenesis, GeneticGlucose Transporter Type 1HumansHypoxia-Inducible Factor 1, alpha SubunitLiposomesNanoparticlesNeoplasmsp300-CBP Transcription FactorsPatents as TopicAntineoplastic AgentsAntioxidantsAscorbic AcidDrug CarriersGlucose Transporter Type 1HIF1A protein, humanHypoxia-Inducible Factor 1, alpha SubunitLiposomesp300-CBP Transcription FactorsReactive Oxygen SpeciesSLC2A1 protein, humananticancerantioxidantascorbic acidcancerepigenetic regulatorHIFpro-oxidant

Identifiers

PMID34439796
PMCPMC8392841
OpenAlexW3191721676

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.